Preclinical and Clinical Evaluation of Intraductally Administered Agents in Early Breast CancerVered Stearns, Saraswati Sukumar, Edward Gabrielson et al.|Science Translational Medicine|2011Cited by 77
Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumorsYong Soon Chun, Saraswati Sukumar, Takahiro Yoshida et al.|Breast Cancer Research and Treatment|2012Cited by 24